Compare WRN & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRN | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.9M | 597.6M |
| IPO Year | 2006 | 2016 |
| Metric | WRN | BVS |
|---|---|---|
| Price | $2.44 | $9.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.88 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.6M | 353.5K |
| Earning Date | 05-08-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.43 |
| Revenue Next Year | N/A | $6.61 |
| P/E Ratio | ★ N/A | $26.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.90 | $5.81 |
| 52 Week High | $4.26 | $9.98 |
| Indicator | WRN | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 56.87 |
| Support Level | $2.43 | $6.43 |
| Resistance Level | $2.56 | $9.01 |
| Average True Range (ATR) | 0.16 | 0.38 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 19.78 | 60.74 |
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.